- Location
Ulcerative Colitis
"-
The FDA Won't Let 23andme Sell Its Personal Genomic Service Tests
Jan 12, 2015The FDA won’t let 23andMe sell its Personal Genomic Service tests to consumers in the United States, but that hasn’t stopped the company from selling its customers’ anonymous information to other companies for research. ...
-
The FDA Has Approved a Non-Invasive Test for Colorectal Cancer
Aug 15, 2014People over 50, rejoice! The FDA has approved a non-invasive test for colorectal cancer, and it may not take years to obtain. Mayo Clinic gastroenterologist David Ahlquist co-invented the test, Cologuard, which detects the presence of ...
-
Potential Breakthrough Drug Might Come From Big Tobacco
Aug 1, 2014Big Tobacco, almost unbelievably, is lending a hand in the creation of a potential breakthrough drug, a new class of drugs that could dull grave psychiatric disorders, improve attention of ADHD afflicted children, repel Alzheimer's onset, ...
Tags: Agriculture, Tobacco, Ecigarette
-
Altheus Therapeutics Has Completed Enrollment for ZA201
Jan 13, 2014Altheus Therapeutics, Inc., announced that it has completed enrollment for ZA201, a 6-week, double-blind, active-controlled Phase 2 clinical trial of the efficacy and safety of Zoenasa® Rectal Gel in approximately 120 adult patients ...
Tags: Altheus Therapeutics, enrollment, ZA201, Zoenasa®Rectal Gel
-
Chances Are Composition of Your Gut Bacteria Undergo a Big Change When Changes in Diet
Dec 27, 2013If you were to switch from vegetarianism to meat-eating, or vice-versa, chances are the composition of your gut bacteria would also undergo a big change, a new study suggests. The research, published Dec. 11 in the journal Nature, showed ...
Tags: gut bacteria, change in diet, animal-based diet, plant-based diet
-
Vedolizumab Is Under Review for The Treatment of Adults
Dec 27, 2013Takeda Pharmaceutical Company Limited ("Takeda") and its wholly-owned subsidiary, Takeda Pharmaceuticals U.S.A., Inc., today announced that the United States (U.S.) Food & Drug Administration (FDA) has extended the Prescription Drug User ...
Tags: Takeda Pharmaceutical Company Limited, Prescription Drug User Fee Act
-
Kraft Foods and Dow Chemical Company Have All Had Issues to Address
Nov 27, 2013A look back through our archives sees that DuPont, Dr Pepper, Post Holdings and Ralcorp Holdings, Kraft Foods and Dow Chemical Company have all had issues to address. General Mills is working to undo the impact of poor waste disposal more ...
Tags: Changing, environmental, issue, food, firm
-
Here Are Five Effective Essential Oils Can Be Used to Treat Chronic Digestive Distress
Nov 21, 2013If you suffer from chronic indigestion, constipation, upset stomach or some other persistent digestive disorder that you are having trouble remedying, essential oils just might be your answer for finding lasting relief. Here are five of the ...
Tags: 5, unbeatable, essential oil, chronic, digestive, distress
-
Second Genome Has Signed a Microbiome Drug Discovery Deal with Janssen Biotech
Jun 8, 2013Second Genome has signed a microbiome drug discovery deal with Janssen Biotech to advance novel drug targets mediated by the bacterial ecosystem living within the human gut to treat ulcerative colitis. Under the collaboration, Janssen ...
Tags: Microbiome Drug, Medicine
-
Trino Therapeutics Received More Than $12m Funding to Advance Ulcerative Colitis Drug
May 29, 2013Drug discovery and early drug development company Trino Therapeutics has received more than €9m ($12m) funding from investors, including Fountain Healthcare Partners and founding investor, the Wellcome Trust, to advance the development ...
Tags: Trino, Colitis Drug
-
Janssen Biotech Has Announced The FDA Approval of Simponi (Golimumab) to Treat Moderately
May 17, 2013Janssen Biotech has announced the FDA approval of Simponi (golimumab) to treat moderately to severely active ulcerative colitis (UC) in adult patients with corticosteroid dependence or an inadequate response to or failed to tolerate oral ...
Tags: FDA, Janssen Biotech
-
IBD has Been Launched Expanded Testing Profile by Labcorp
Apr 2, 2013Laboratory Corporation of America (LabCorp) has launched an expanded testing menu to help clinicians diagnose, treat and monitor the course of inflammatory bowel disease (IBD). The menu comprises IBD Expanded Profile that includes ...
Tags: Labcorp, Expanded Testing Profile, Inflammatory Bowel Disease
-
Takeda Pharmaceutical Company Has Submitted MAA Seeking Approval From The EMA
Mar 11, 2013Takeda Pharmaceutical Company has submitted marketing authorisation application (MAA) seeking approval from the European Medicines Agency (EMA) for its investigational, gut-selective humanized monoclonal antibody for the treatment of adults ...
Tags: Takeda, IBD Disease Drug, MAA, EMA
-
Santarus Has Announced The Commercial Launch of Ulcerative Colitis Therapy
Feb 19, 2013Specialty biopharmaceutical company Santarus has announced the commercial launch of ulcerative colitis therapy, Uceris (budesonide) extended release tablets. Uceris that contains a locally acting glucocorticosteroid, budesonide, in a ...
Tags: Santarus, Uceris, ulcerative colitis therapy
-
The US FDA Has Approved Warner Chilcott's 400mg Mesalamine Product
Feb 13, 2013The US FDA has approved Warner Chilcott's 400mg mesalamine product as new ulcerative colitis therapy, to be marketed as Delzicol. Warner expects to commercially launch Delzicol in March 2013. Delzicol delayed-release capsules are ...
Related Products
-
Anti Ulcerative Colitis Drug Agent Powder CAS 150399-21-6 Balsalazide Disodium
-
Anti Ulcerative Colitis Drug Agent Powder CAS 80573-04-2 Balsalazide
-
Delightful Microorganism Avails Human Bifidobacterium Breve
-
Effective 150b Cfu/G Probiotics Supplement Capsule B. Breve
-
Health Effective Probiotics Nutrition Enhancer Tablet Bifidobacterium Breve
